TIME T2D DISRUPT
Mark Identification

TIME T2D DISRUPT

Serial Number

86530794

Filing Date

Feb 10, 2015

Trademark by

INTARCIA THERAPEUTICS INC.

Classification Information

Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases and disorders; drug delivery systems comprised of an implantable pump filled with pharmaceutical preparations for use in treating diabetes, obesity and metabolic diseases/disorders

Pharmaceuticals

Drug delivery systems, namely, an implantable pump; medical apparatus for the administration of pharmaceuticals in the nature of an implantable pump; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders in the nature of an incretin memetic pump

Medical Apparatus

Development and dissemination of printed and electronic educational materials of others in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of diabetes, obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith

Education and Entertainment

Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; medical and scientific research in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; providing information in the fields of clinical trials of pharmaceuticals

Computer and Scientific

Medical information services, namely, providing information on the topics of diabetes, obesity, and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, pharmaceuticals, drug delivery technologies, and administration of pharmaceuticals

Medical, Beauty & Agricultural